Searchable abstracts of presentations at key conferences in endocrinology

ea0037ep833 | Thyroid cancer | ECE2015

Sarcoidosis in a 53-year-old women followed for a refractory thyroid carcinoma: a misleading association

Thuillier Philippe , Roudaut Nathalie , Kerlan Veronique , Emmanuel Sonnet

Sarcoïdosis is a relatively frequent systemic disease of unknown origin. Prevalence is about 4.7–64 in 100 000. We report the case of a 53-year-old woman followed in our institution since 2007 for a thyroid carcinoma. In 2010, she was diagnosed refractory thyroid carcinoma because of a high thyroglobulin assay (477 μg/l) without uptake on post-therapeutic (131I) whole body scan. Thereafter, the story is marked by the appearance in 2011 of multiple cer...

ea0070oc5.5 | Thyroid | ECE2020

Thyroid dysfunction induced by immune checkpoint inhibitors is associated with a better progression-free-survival and overall survival in non-small cell lung cancer: an original cohort study

Thuillier Philippe , Joly Claire , Roudaut Nathalie , Crouzeix Geneviève , Descourt Renaud , Kerlan Véronique

Objective: Immune checkpoint inhibitors (ICI) are used for treatment of non-small cell lung cancer (NSCLC) and are associated with immune-related adverse events (irAEs), especially thyroid dysfunction. Few studies found an association between thyroid dysfunction and response to Nivolumab in the NSCLC The objective of this retrospective cohort study was to investigate the association between the occurrence of thyroid dysfunction in patients treated with Nivolumab for a NSCLC an...